Evidence map›Paper›PMID 38955837›Full record

ArticleSurgical endoscopy2024

Safety of robotic cholecystectomy as index training procedure: the UK experience.

Irena Stefanova, Omar Alkhatib, Andrea Sheel, Edward Alabraba, Mohammad Alibrahim, Ali Arshad, Altaf Awan, Ryan Baron, Imran Bhatti, Ricky Bhogal and 30 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors.

Irena StefanovaRoyal Surrey County Hospital NHS Foundation Trust, Guilford, UK. irena.stefanova@nhs.net.ORCID 0000-0002-4024-0514
Omar AlkhatibRoyal Liverpool Hospital NHS Foundation Trust, Liverpool, UK.
Andrea SheelRoyal Liverpool Hospital NHS Foundation Trust, Liverpool, UK.
Edward AlabrabaNottingham University Hospitals NHS Trust, Nottingham, UK.
Mohammad AlibrahimLeeds Teaching Hospitals NHS Trust, Leeds, UK.
Ali ArshadUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Altaf AwanUniversity Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
Ryan BaronRoyal Liverpool Hospital NHS Foundation Trust, Liverpool, UK.
Imran BhattiUniversity Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
Ricky BhogalThe Royal Marsden NHS Foundation Trust, London, UK.
Vijayanand DhakshinamoorthyUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Rafael Diaz-NietoRoyal Liverpool Hospital NHS Foundation Trust, Liverpool, UK.
Declan DunneRoyal Liverpool Hospital NHS Foundation Trust, Liverpool, UK.
Adam E FramptonRoyal Surrey County Hospital NHS Foundation Trust, Guilford, UK.
Alexander GreenNorthumbria Healthcare NHS Foundation Trust, Newcastle-Upon-Tyne, UK.
Shahin HajibandehUniversity Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Zaed HamadyUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Liam HorganNorthumbria Healthcare NHS Foundation Trust, Newcastle-Upon-Tyne, UK.
Eleanor KissaneNewcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, UK.
Sailakshmi KrishnanHull University Teaching Hospitals NHS Trust, Hull, UK.
Rajesh KumarRoyal Surrey County Hospital NHS Foundation Trust, Guilford, UK.
Rajiv LahiriRoyal Surrey County Hospital NHS Foundation Trust, Guilford, UK.
Shi LamCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Siong-Seng LiauCambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
Gabriele MarangoniUniversity Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
Shyam MoudhgalyaNewcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, UK.
Georgios PapadopoulosUniversity Hospital Southampton NHS Foundation Trust, Southampton, UK.
Tim PencavelRoyal Surrey County Hospital NHS Foundation Trust, Guilford, UK.
Sarah PickerNorthumbria Healthcare NHS Foundation Trust, Newcastle-Upon-Tyne, UK.
Jason RamsinghNewcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle-Upon-Tyne, UK.
Angela RigaRoyal Surrey County Hospital NHS Foundation Trust, Guilford, UK.
Michael SilvaOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Zahir SoonawallaOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Daren SubarEast Lancashire Hospitals NHS Trust, Burnley, UK.
Vikas SudOxford University Hospitals NHS Foundation Trust, Oxford, UK.
Vivek UpasaniLeeds Teaching Hospitals NHS Trust, Leeds, UK.
Vincent WongHull University Teaching Hospitals NHS Trust, Hull, UK.
Tim WorthingtonRoyal Surrey County Hospital NHS Foundation Trust, Guilford, UK.
Kai Tai Derek YeungThe Royal Marsden NHS Foundation Trust, London, UK.
Jawad AhmadUniversity Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo evaluate the safety profile of robotic cholecystectomy performed within the United Kingdom (UK) Robotic Hepatopancreatobiliary (HPB) training programme.

methodsA retrospective evaluation of prospectively collected data from eleven centres participating in the UK Robotic HPB training programme was conducted. All adult patients undergoing robotic cholecystectomy for symptomatic gallstone disease or gallbladder polyp were considered. Bile duct injury, conversion to open procedure, conversion to subtotal cholecystectomy, length of hospital stay, 30-day re-admission, and post-operative complications were the evaluated outcome parameters.

resultsA total of 600 patients were included. The median age was 53 (IQR 65-41) years and the majority (72.7%; 436/600) were female. The main indications for robotic cholecystectomy were biliary colic (55.5%, 333/600), cholecystitis (18.8%, 113/600), gallbladder polyps (7.7%, 46/600), and pancreatitis (6.2%, 37/600). The median length of stay was 0 (IQR 0-1) days. Of the included patients, 88.5% (531/600) were discharged on the day of procedure with 30-day re-admission rate of 5.5% (33/600). There were no bile duct injuries and the rate of conversion to open was 0.8% (5/600) with subtotal cholecystectomy rate of 0.8% (5/600).

conclusionThe current study confirms that robotic cholecystectomy can be safely implemented to routine practice with a low risk of bile duct injury, low bile leak rate, low conversion to open surgery, and low need for subtotal cholecystectomy.

Indexed as

Postoperative ComplicationsRobotic Surgical ProceduresAdultAgedCholecystectomyConversion to Open SurgeryFemaleHumansLength of StayMaleMiddle AgedPatient ReadmissionRetrospective StudiesUnited KingdomBile duct injuryCholecystectomyRoboticsRobotic surgery

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.